Stent Versus Balloon Dilatation in Patients With Tracheal Benign Stenosis
- Conditions
- Tracheal Stenosis
- Interventions
- Procedure: Stent placement
- Registration Number
- NCT04674995
- Lead Sponsor
- University of Modena and Reggio Emilia
- Brief Summary
This is a retrospective, observational cohort study carried out in two operative Units of the University Hospital of Modena (Italy): the Diagnostic and Interventional Bronchoscopy Unit (Unit A) and the Otolaryngology Unit (Unit B). The two units have different protocols routinely applied to treat tracheal benign stenosis. In Unit A, endoscopic treatment is performed through mechanical dilatation via rigid bronchoscopy and further stent placing while in Unit B the endoscopic treatment is performed through balloon dilatation via direct laryngoscopy. The primary purpose was to compare the efficacy of the two technique on tracheal stenosis treatment over time. Patients were defined as "cured" if during the 2 years after 12 months since the last intervention they did not present any of the following: respiratory symptoms, need for a re-intervention or stenosis instability.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- age >18 years,
- exclusion from resection-anastomosis surgery after multidisciplinary evaluation,
- Cotton Meyer > grade II,
- follow-up of at least 3 years after endoscopic surgery,
- no previous tracheal surgery.
- age > 80,
- stent intolerance which requires removal in the first year after endoscopic treatment,
- performance status > 2,
- end-stage chronic pulmonary disease,
- life-threatening stenosis that needs urgent endoscopic treatments,
- any neoplastic stenosis of the airways,
- dynamic etiology of tracheal benign stenosis (excessive dynamic airway collapse, tracheobronchomalacia).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Stent Stent placement Patients with tracheal stenosis treated with stent placement via rigid bronchoscopy.
- Primary Outcome Measures
Name Time Method Re-stenosis rate over time 36 months Patients were defined as cured if during the 2 years after 12 months since the last intervention they did not present any of the following: respiratory symptoms, need for a re-intervention or stenosis instability.
- Secondary Outcome Measures
Name Time Method